Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Clinical Oncology 6, 127 (1 March 2009) | doi:10.1038/ncponc1315
Vasomotor or joint symptoms as a marker of endocrine response in breast cancer
Abstract
Cuzick J et al. (2008) Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial. Lancet Oncol 9: 1143–1148 In women with breast cancer vasomotor and joint symptoms are common adverse effects of endocrine treatment.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
